Biotricity Net Income From Continuing Ops from 2010 to 2026

BTCY Stock  USD 0.31  0  0.54%   
Biotricity Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to about -8 M in 2026. During the period from 2010 to 2026, Biotricity Net Loss regression line of annual values had significance of  0.01 and arithmetic mean of (8,890,661). View All Fundamentals
 
Net Loss  
First Reported
2016-03-31
Previous Quarter
-672 K
Current Value
-690.9 K
Quarterly Volatility
M
 
Yuan Drop
 
Covid
Check Biotricity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotricity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 K, Interest Expense of 6.3 M or Selling General Administrative of 9.8 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0035 or Days Sales Outstanding of 141. Biotricity financial statements analysis is a perfect complement when working with Biotricity Valuation or Volatility modules.
  
Build AI portfolio with Biotricity Stock
Check out the analysis of Biotricity Correlation against competitors.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Latest Biotricity's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Biotricity over the last few years. It is Biotricity's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biotricity's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Biotricity Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(8,890,661)
Coefficient Of Variation(82.29)
Mean Deviation5,175,026
Median(7,958,014)
Standard Deviation7,316,004
Sample Variance53.5T
Range27.4M
R-Value(0.59)
Mean Square Error37T
R-Squared0.35
Significance0.01
Slope(859,812)
Total Sum of Squares856.4T

Biotricity Net Income From Continuing Ops History

2026-8 M
2025-7.6 M
2024-8.4 M
2023-14.1 M
2022-18.7 M
2021-29.1 M
2020-15.5 M

About Biotricity Financial Statements

Biotricity investors use historical fundamental indicators, such as Biotricity's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biotricity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-7.6 M-8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biotricity Stock Analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.